[1]张文学,姜炜,只达石.全中枢系统合并局部后颅窝加量照射髓母细胞瘤疗效分析[J].国际放射医学核医学杂志,2007,31(6):384-386.
 ZHANG Wen-xue,JIANG Wei,ZHI Da-shi.The Prognostic Analysis of Whole Nervous System and Posterior Fossa Irradiation for Patients with Cerebellar Medulloblastoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(6):384-386.
点击复制

全中枢系统合并局部后颅窝加量照射髓母细胞瘤疗效分析(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
31
期数:
2007年第6期
页码:
384-386
栏目:
临床放射医学
出版日期:
1900-01-01

文章信息/Info

Title:
The Prognostic Analysis of Whole Nervous System and Posterior Fossa Irradiation for Patients with Cerebellar Medulloblastoma
作者:
张文学12 姜炜1 只达石2
1. 300060 天津, 天津市环湖医院立体定向放射神经外科;
2. 300052 天津, 天津医科大学总医院神经外科
Author(s):
ZHANG Wen-xue12 JIANG Wei1 ZHI Da-shi2
1. Department of Neurosurgery, General Hospital of Tianjin Medical University, 300052;
2. Department of Stereotactic Radiation Neurosurgery, Huanhu Hospital of Tianjin, 300060, China
关键词:
髓母细胞瘤放射疗法预后
Keywords:
Cerebellar medulloblastomaRaditherapy
分类号:
R815.2
摘要:
目的 回顾分析29例髓母细胞瘤患者术后行全脑、全脊髓放疗的效果。方法 对1996年至2005年我科治疗的已有明确病理的髓母细胞瘤患者,放疗后长期随访,分析其预后。结果 29例小脑髓母细胞瘤患者放疗后3年、5年生存率分别为66.2%和62.1%。结论 髓母细胞瘤患者术后放疗效果满意,无明显副反应。手术情况和全脊髓照射剂量为其预后的影响因素。
Abstract:
Objective To analyze the results of whole nervous system and posterior fossa irradiation for 29 post-oprative patients with cerebellar medulloblastoma. Methods Long term follow-up is exerted for the pathology-confirmation cerebellar medulloblastoma patients between 1996 and 2005. Tbe results is analyzed. Results 3 year and 5 year survival rate is 66.2% and 62.1% repectively. Conclusions The treatment results for the patients is satisfactory, with little side-effect. The result of surgery and the dose for the spiral could be prognostic factors.

参考文献/References:

1 章翔.神经系统肿瘤学.第1版,北京:军事医学科学出版社,1999.322.
2 毛卫东,陆雪官,田野.14例小脑髓母细胞瘤全脑全脊髓照射疗效分析.苏州大学学报医学版,2005,25(2):288-290.
3 殷蔚伯,谷铣之.肿瘤放射治疗学.第3版.北京:中国协和医科大学出版社,2002.1025-1029.
4 Sachivko NV, Konolia NE, Petrovich SV, et al. Role of adjuvant chemotherapy in the treatment of medulloblastoma in children Sharak EV. Vopr Onkol, 2002, 48(3):318-321.

相似文献/References:

[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
 Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]刘佳,高刚,朴春南,等.调节肿瘤放射敏感性的miRNAs研究进展[J].国际放射医学核医学杂志,2016,40(2):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
 Liu Jia,Gao Gang,Piao Chunnan,et al.Progress of microRNAs in regulating tumor radiation sensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
[3]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
 Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[4]赵德云,李百龙.植物提取物防治放射性肺损伤的现状与展望[J].国际放射医学核医学杂志,2016,40(3):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
 Zhao Deyun,Li Bailong.Protective and therapeutic effects of plant extracts on radiation-induced lung injury:present status and future prospects[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
[5]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
 Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[6]邓大平,卢峰,孙洪强,等.颅脑肿瘤放射治疗时射野外器官吸收剂量体模法测量与分析[J].国际放射医学核医学杂志,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
 Deng Daping,Lu Feng,Sun Hongqiang,et al.Test and analysis of out-of-field organ dose in intracranial tumor radiotherapy using phantom[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
[7]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
 zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[8]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
 Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[9]段永璇,邹晓艳,段秀梅,等.数据解析在肿瘤放射治疗中的应用[J].国际放射医学核医学杂志,2015,39(6):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
 Duan Yongxuan,Zou Xiaoyan,Duan Xiumei,et al.Data analysis in the field of tumor radiation therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
[10]贾立立,孟粹达,刘晓冬,等.头颈部肿瘤放疗中转化医学相关机制的研究进展[J].国际放射医学核医学杂志,2015,39(3):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
 Jia Lili,Meng Cuida,Liu Xiaodong,et al.Development in translational medicine-related mechanisms of radiotherapy for head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]

备注/Memo

备注/Memo:
收稿日期:2007-01-17。
通讯作者:张文学,E-mail:fortunator5658@eyou.com
更新日期/Last Update: 1900-01-01